ErnieRifferMD

Internal Medicine • Phoenix, AZ

Physician

Join to view full profile

Dr. Riffer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Riffer's full profile

Already have an account?

Office
7600 N 15th St
#190
Phoenix, AZ 85020
Phone+1 602-200-3800

Fax+1 602-200-3838

Education & Training

University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 1986 - 1989
University of Illinois College of MedicineClass of 1986

Certifications & Licensure

AZ State Medical License 1988 - 2026
TX State Medical License 1990 - 1995
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Aprima EHR, Aprima Medical Software, Inc., 2012-2013

Clinical Trials

A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease Start of enrollment: 2011 Nov 01
Completed
Phase 2
A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol Start of enrollment: 2014 Oct 01
Terminated
Phase 3
Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01
Completed
Not Applicable

Publications & Presentations

PubMed

18 citations
Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
C. Andrew DeAbate, Robert B. Bettis, Zev M. Munk, Harold Fleming, Nancy Munn
Clinical Therapeutics. 1999-01-01
43 citations
Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women
Dan C. Henry, Robert B. Bettis, Ernie Riffer, Daniel Haverstock, Steven F. Kowalsky
Clinical Therapeutics. 2002-12-01
36 citations
A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia.
Mark H. Gotfried, Dan Dattani, Ernie Riffer, Karen J. Devcich, Todd A. Busman
Clinical Therapeutics. 2002-05-01

Press Mentions

Inovio’s Recent Data Fails to Impress Some Analysts but Overall Data Looks Promising & Study Backed by Department of DefenseDecember 29th, 2020